To explore the potential molecular mechanism by which sja-miR-61 inhibited in vivo growth of hepatoma, we detected the expression levels of both Ki67 and CD34 using immunohistochemistry (IHC). The gene discussed is CD34; the disease is hepatocellular carcinoma.